Tumor Board Session 4: Clival Chordoma
18th February, 2023, 14:25 - 15:25
Tampa Bay 9
This session will be focused on reviewing current data to achieve a consensus on best practices for the management of Clival Chordomas. It will target students, residents, junior, and senior faculty members who manage patients with Clival Chordomas.
Objectives
At the conclusion of this session, attendees will be able to:
- Diagnose and illustrate key radiographic and pathologic features of Clival Chordomas.
- Discuss the role of molecular subtyping in the characterization of Clival Chordomas.
- Formulate a surgical approach and treatment plan for Clival Chordomas, discussing both open and endoscopic routes.
- Evaluate the pros and cons of radiation treatment as an alternative to or adjunct to surgery for Clival Chordomas.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
| Speaker | Title | Role | Times |
|---|---|---|---|
| Chandranath Sen 212-263-5333 |
Moderator | - | |
| Bree Eaton 404-778-3473 |
Moderator | - | |
| Chandranath Sen 212-263-5333 |
Case Presentation | Speaker | 2:25 pm - 2:35 pm |
| Mai-Lan Ho 6148004189 |
Radiology Review | Speaker | 2:35 pm - 2:45 pm |
| Nathan Zwagerman 4146144021 |
Surgical Options and Choice of Approach | Speaker | 2:45 pm - 2:55 pm |
| Rupesh Kotecha 786-999-4267 |
Role of Radiotherapy and Choice of Platform | Speaker | 2:55 pm - 3:05 pm |
| Stewart Neill 404-712-7320 |
Pathology Review (Including Molecular Subtyping) | Speaker | 3:05 pm - 3:15 pm |
| |
Q&A | 3:15 pm - 3:25 pm |